Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
Dry Eye Syndromes, Inflammation, Microvessels
About this trial
This is an interventional health services research trial for Dry Eye Syndromes
Eligibility Criteria
Inclusion Criteria:
- age ≧ 18 years
- Ocular Surface Disease Index (OSDI) ≧ 12.
- A 5-min Schirmer I test (ST) result showing less than 5 mm of moisture on the strip.
- A noninvasive average tear-film break-up time (NI-avBUT) less than 5 s.
Exclusion Criteria:
- Patients were excluded if they had an eye infection, injury, non-DE ocular inflammation, ocular surgery within the last 6 months, or any concurrent treatment that might interfere with the interpretation of the study results (systemic corticosteroids, immunosuppressive therapy, or hormonal replacement therapy). Patients were also excluded if they had an uncontrolled disease, had a significant illness or were pregnant or lactating.
Sites / Locations
- Wan ChenRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Dry eye group
Control group
The recruitment of subjects met the criteria of DEWS. Each subject received treatment based on increasing severity according to the expert consensus for the treatment of DE inflammation. For moderate levels of severity, topical anti-inflammatory agents (0.1% Fluorometholone) were administered twice daily and then gradually less frequently until inflammation was controlled. For severe DE, the approach was similar to that of the moderate level but with an increased concentration and treatment frequency of the anti-inflammatory agents (0.1% Fluorometholone, 4 times daily). Topical 0.05% tacrolimus twice daily when DE was extremely severe. Functional Slit-Lamp Biomicroscopy were administrated to collected data from this group.
Normal health subject without drug intervention, Functional Slit-Lamp Biomicroscopy were administrated to collected data from this group.